[go: up one dir, main page]

DK0505966T3 - Langtidsvirkende bionedbrydelige mikropartikler og en fremgangsmåde til fremstilling deraf - Google Patents

Langtidsvirkende bionedbrydelige mikropartikler og en fremgangsmåde til fremstilling deraf

Info

Publication number
DK0505966T3
DK0505966T3 DK92104995.3T DK92104995T DK0505966T3 DK 0505966 T3 DK0505966 T3 DK 0505966T3 DK 92104995 T DK92104995 T DK 92104995T DK 0505966 T3 DK0505966 T3 DK 0505966T3
Authority
DK
Denmark
Prior art keywords
long
preparation
biodegradable microparticles
acting
acting biodegradable
Prior art date
Application number
DK92104995.3T
Other languages
English (en)
Inventor
Norbert Dr Lill
Juergen Dr Sandow
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0505966T3 publication Critical patent/DK0505966T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK92104995.3T 1991-03-25 1992-03-23 Langtidsvirkende bionedbrydelige mikropartikler og en fremgangsmåde til fremstilling deraf DK0505966T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4109746 1991-03-25

Publications (1)

Publication Number Publication Date
DK0505966T3 true DK0505966T3 (da) 1995-10-30

Family

ID=6428150

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92104995.3T DK0505966T3 (da) 1991-03-25 1992-03-23 Langtidsvirkende bionedbrydelige mikropartikler og en fremgangsmåde til fremstilling deraf

Country Status (20)

Country Link
EP (1) EP0505966B1 (da)
JP (1) JP3346789B2 (da)
KR (1) KR100203253B1 (da)
AT (1) ATE124254T1 (da)
AU (1) AU653210B2 (da)
CA (1) CA2063883C (da)
CY (1) CY2032A (da)
CZ (1) CZ284756B6 (da)
DE (1) DE59202649D1 (da)
DK (1) DK0505966T3 (da)
ES (1) ES2076592T3 (da)
FI (1) FI99084C (da)
HR (1) HRP940838B1 (da)
IE (1) IE67555B1 (da)
IL (1) IL101346A0 (da)
MY (1) MY109719A (da)
NO (1) NO302856B1 (da)
NZ (1) NZ242073A (da)
YU (1) YU48420B (da)
ZA (1) ZA922130B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2079509C (en) * 1991-10-01 2002-05-14 Shigeyuki Takada Prolonged release microparticle preparation and production of the same
JP2651320B2 (ja) * 1992-07-16 1997-09-10 田辺製薬株式会社 徐放性マイクロスフェア製剤の製造方法
AU4198793A (en) * 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
ATE175132T1 (de) * 1992-10-26 1999-01-15 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung von mikrokapseln
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
CA2192782C (en) * 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
KR100321854B1 (ko) * 1998-12-30 2002-08-28 동국제약 주식회사 루테이나이징 호르몬 릴리싱 호르몬 동족체를 함유하는 장기 서방출성 미립구 및 그의 제조방법
CN1520313A (zh) 2001-05-23 2004-08-11 ������ҩ��ʽ���� 一种加速骨折愈合的组合物
ES2427930T3 (es) 2001-05-23 2013-11-04 Mitsubishi Tanabe Pharma Corporation Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos
CA2490351C (en) 2002-06-25 2011-11-01 Takeda Pharmaceutical Company Limited Process for producing sustained-release composition
JP4792457B2 (ja) * 2004-03-26 2011-10-12 ユニヴァーシタ’デグリ ステュディ ディ パルマ 高度に呼吸に適したインスリンのマイクロ粒子
KR100722607B1 (ko) 2006-05-11 2007-05-28 주식회사 펩트론 분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
FR2934856B1 (fr) * 2008-08-05 2010-08-13 Servier Lab Nouveau procede d'obtention de la forme cristalline v de l'agomelatine
BR102012011209A2 (pt) * 2012-05-11 2014-03-25 Bioactive Biomateriais Ltda Material tridimensional polimérico biodegradável e processo de preparo de material tridimensional polimérico biodegradável
CN105963257B (zh) * 2016-04-26 2021-01-22 广州帝奇医药技术有限公司 一种缓释微粒的制备方法
CN105963258B (zh) * 2016-04-26 2021-01-22 广州帝奇医药技术有限公司 一种缓释微粒的制备方法
CN109985585A (zh) * 2019-05-13 2019-07-09 苏州岸谷纳米技术有限公司 一种生物降解高分子微球的快速制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
EP0318492A1 (en) * 1986-08-11 1989-06-07 Innovata Biomed Limited Pharmaceutical formulations comprising microcapsules
DE3710175A1 (de) * 1987-02-12 1988-08-25 Hoechst Ag Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
DE3738228A1 (de) * 1987-11-11 1989-05-24 Hoechst Ag Verfahren zur herstellung von bioabbaubaren mikrokapseln wasserloeslicher peptide und proteine sowie nach diesem verfahren erhaltene mikrokapseln
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier

Also Published As

Publication number Publication date
KR100203253B1 (ko) 1999-06-15
ES2076592T3 (es) 1995-11-01
FI99084C (fi) 1997-10-10
KR920017645A (ko) 1992-10-21
ATE124254T1 (de) 1995-07-15
FI921248L (fi) 1992-09-26
CA2063883C (en) 2001-12-11
MY109719A (en) 1997-05-31
HRP940838B1 (en) 2000-12-31
AU1310992A (en) 1992-10-01
CS88792A3 (en) 1992-10-14
JP3346789B2 (ja) 2002-11-18
JPH0570363A (ja) 1993-03-23
IE67555B1 (en) 1996-04-17
DE59202649D1 (de) 1995-08-03
FI921248A0 (fi) 1992-03-23
AU653210B2 (en) 1994-09-22
NZ242073A (en) 1993-08-26
NO302856B1 (no) 1998-05-04
HRP940838A2 (en) 1997-06-30
NO921147L (no) 1992-09-28
EP0505966B1 (de) 1995-06-28
CZ284756B6 (cs) 1999-02-17
CY2032A (en) 1998-02-20
IE920956A1 (en) 1992-10-07
NO921147D0 (no) 1992-03-24
EP0505966A1 (de) 1992-09-30
CA2063883A1 (en) 1992-09-26
FI99084B (fi) 1997-06-30
YU26392A (sh) 1994-12-28
YU48420B (sh) 1998-07-10
IL101346A0 (en) 1992-11-15
ZA922130B (en) 1992-11-25

Similar Documents

Publication Publication Date Title
DK0505966T3 (da) Langtidsvirkende bionedbrydelige mikropartikler og en fremgangsmåde til fremstilling deraf
FI922620L (fi) Peptidderivat, foerfarande foer dess framstaellning, ett farmaceutisk preparat innehaollande detta och foerfarande foer behandling av glaukoma.
NL300181I2 (nl) N-(pyrroloÖÄ2,3-dÖÜpyrimidine-3-ylacyl)-glutaminezuurderivaten.
FI911763L (fi) Ammoniumsalter av n5-metyl-5,6,7,8 -tetrahydrofolsyra.
DE3888357D1 (de) Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen.
ITMI920062A1 (it) Sistema per l'azionamento di morsetti per una struttura di bloccaggio portata da un trasportatore
FI923031A0 (fi) 1,4-bis-(amino-hydroxialkylamino)- antrakinoner foer inhibering av proteinkinas c.
FI945313L (fi) Parannetun biokäytettävyyden omaavat tabletit, jotka sisältävät dikloorimetyleenifosfonihappoa vaikuttavana aineena
MA23044A1 (fr) Derives insecticides de 2,4-dianinopyrimidines-5-substitues.
FI930261A7 (fi) Polypeptidiyhdisteitä, joilla on kasvuhormonia vapauttava vaikutus
TR28873A (tr) N-sübstitüe edilmis, N,N'-kaynasik heterosiklik benzoik asit üretmeye mahsus yöntem.
FR2669636B1 (fr) Procede de fabrication de furane 2,5-dicarboxaldehyde.
FR2661070B1 (fr) Compositions insecticides a base de chrysanthemate de 2,4-dioxo-1-(2-propynyl) imidazolidine-3-ylmethyle.
FI98459B (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi
FR2733249B1 (fr) Lipase gastrique de chien recombinante et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations
DE59000099D1 (de) Geschlossenes landwirtschaftliches feldspritzensystem.
DE69122555D1 (de) 2,4-Dihydroxyadipinsäurederivate
DE59004593D1 (de) Landwirtschafliche Feldspritze.
FI952462L (fi) Menetelmä 1,3-oksatsolidin-5-karboksyylihapon valmistamiseksi
DE58903270D1 (de) Loesungsmittelaufbereitungsanlage.
NO892755L (no) Fremgangsmaate til fremstilling av 5,6,7,8-tetrahydro-4h-isoksazol(4,5-d)-azepin-3-olderivater.
DE69105347D1 (de) Originalitätsgesicherte Sprühvorrichtung.
FI102538B1 (fi) LH-RH-analogien synteesi väliaikaisella, pienimmällä mahdollisella suojauksella
DE59000339D1 (de) Landwirtschaftliche feldspritze.
İsmayılzade Böyük Qudsi ve Azerbaycan Arxeologiyasının Sübh Çağı